Showing 1491-1500 of 1735 results for "".
- Retina Specialist Brett Foxman, MD, Earns U.S. Patent for Scleral Depressorhttps://modernod.com/news/retina-specialist-brett-foxman-md-earns-u-s-patent-for-scleral-depressor/2476788/Brett Foxman, MD, Clinical Service Chief in Ophthalmology at Shore Medical Center in Somers Point, New Jersey, recently won a U.S. patent for his new version of the scleral depressor. Dr. Foxman said after performing thousands of eye surgeries using a tool that had stayed essentially uncha
- Perspective: Protocol V Sheds Light on Managing Mild Diabetic Macular Edemahttps://modernod.com/news/perspective-protocol-v-sheds-light-on-managing-mild-diabetic-macular-edema/2479555/When it comes to the treatment of diabetic macular edema (DME), ophthalmologists have overwhelming evidence to guide their decision-making—but only up to a point. DME consists of three clinical subcategories: center-involved DME (CI-DME) with visual acuity (VA) impairment, CI-DME with good
- EKF Quo-Test Supports Improved Medical Management of Diabetic Retinopathy Patientshttps://modernod.com/news/ekf-quo-test-supports-improved-medical-management-of-diabetic-retinopathy-patients/2476736/EKF Diagnostics announced that its Quo-Test HbA1c analyzer is supporting improved medical management of patients with sight-threatening diabetic retinopathy (DR). The effectiveness of this point-of-care HbA1c testing application for rapid assessment of glycaemic control in eye clinic patients has
- Ellex to Launch Innovative New Ultrasound Technology at ASCRShttps://modernod.com/news/ellex-to-launch-innovative-new-ultrasound-technology-at-ascrs/2476552/Ellex Medical Lasers announced the market launch of the company’s Eye Prime diagnostic ultrasound technology that is essential for evaluating pathology of the eye. FDA clearance was received on April 12, 2019. This proprietary diagnostic advance features a multifocal array of 6 focal point
- I-PEN Osmolarity System Now Available in Brazil Through Partnership with DryComhttps://modernod.com/news/i-pen-osmolarity-system-now-available-in-brazil-through-partnership-with-drycom/2476420/The I-PEN is the world’s first, point-of-care, electronic diagnostic testing device to detect and indirectly measure the tear film osmolarity levels associated with marginal, mild, moderate and severe dry eye disease. The I-PEN Osmolarity System, used in conjunction with the I-PEN Osmolarity Sing
- Gottlieb’s Quick Goodbye Triggers Investor Panic, Biopharma Bewildermenthttps://modernod.com/news/gottliebs-quick-goodbye-triggers-investor-panic-biopharma-bewilderment/2476360/When FDA Commissioner Scott Gottlieb got his job, critics called him a shill and industry types figured they’d gained a friend in the most important drug regulatory agency in the world. It didn’t turn out quite that way. Gottlieb was biopharma-friendly—to the point where the Na
- Nexy Robotic Retinal Imaging System Receives FDA Clearancehttps://modernod.com/news/nexy-robotic-retinal-imaging-system-receive-fda-clearance/2480097/Konan Medical USA announced that the Nexy retinal camera received FDA 510(k) clearance and is now available in the United States. The Nexy features fully robotic operation and is designed for use in ophthalmology, optometry, hospitals, clinics and many other point-of-servic
- Siemens Healthineers and Hill-Rom to Provide Comprehensive Diabetes Care for Primary Care Facilitieshttps://modernod.com/news/siemens-healthineers-and-hill-rom-to-provide-comprehensive-diabetes-care-for-primary-care-facilities/2480156/Siemens Healthineers and Hill-Rom signed a co-marketing agreement to provide a suite of point-of-care diagnostic instruments that, for the first time, enable primary healthcare providers in the United States to bridge gaps in diabetes care and satisfy value-based quality measures in a single offi
- EyeDura's Sustained-Release Eye Drop Technology Wins Industry Honorshttps://modernod.com/news/eyeduras-sustained-release-eye-drop-technology-wins-industry-honors/2482886/EyeDura Therapeutics, developer of preservative-free sustained release ophthalmic therapies, announced it received top recognition at two major industry forums among a field of ophthalmic startup companies. EyeDura won 'The Winning Pitch' challeng
- Cost, Purchase Factors, and Correct Usage Drive Online Contact Lens Searcheshttps://modernod.com/news/cost-purchase-factors-and-correct-usage-drive-online-contact-lens-searches-according-to-new-research-in-the-us-and-canada/2482671/New research from the Contact Lens Institute (CLI) demonstrates that purchase factors–specificly contact lens retailers and price–are the primary driver of consumer online contact lens-related searches, representing 65% of top 20 searches in the United States and Canada. Oth